Introduction
Fructo-oligosaccharides consist of several fructosyl residues linked to a terminal glucose moiety. They occur naturally in many plant species, such as onion, edible burdock, asparagus, wheat and so on. These fructo-oligosaccharides are commercially produced from sucrose by the transfructosylation reaction of an enzyme or from inulin by enzymatic hydrolysis. This paper reviews the beneficial characteristics of fructo-oligosaccharides in relation to human health. Many studies have shown that administration of fructo-oligosaccharides improves the intestinal flora, resulting in relief of constipation, improvement of the blood lipid composition in hyperlipidaemia and suppression of the production of intestinal putrefactive substances. The bio-availability in man and the application of these saccharides to foods will also be discussed.
Structure and enzymatic preparation

Structure
Fructo-oligosaccharides consist of one sucrose moiety and several fructose moieties which combine with fructose 1-hydroxy groups in a 20-Abbreviations used: GFI, 1-kestose; GF :. nystose; GF,, I'-B-fructofuranosylnystose; LJ,, transfructosylating activity; LJ,,, hydrolysing activity; HLII., high density lipoprotein; IL)L, low density lipoprotein; SCFA, short-chain fatty acids.
bond. The representative compounds are 1 -kestose (GF?), nystose (GF,) and lF-/3-fructofuranosylnystose (GF,), as shown in Fig. 1 (Fig. 1) . The procedure of industrial production has been developed as follows. A sucrose syrup of 50-60% (w/v) is run through an immobilized A. niger enzyme column for transfructosylation, followed by an active carbon column and an ion exchange column for decolorization and desalination. There are two types of commercially available fructo-oligosaccharides, Neosugar G and Neosugar P. Neosugar G is obtained from the enzymatic reaction mixture by a purification process of decolorization and desalination, and Neosugar P is prepared from Neosugar G by removing monosaccharides and disaccharides. Neosugar G consists of 35% (w/w) glucose and fructose, 10% (w/w) sucrose and 55% (w/w) fructo-oligosaccharides, comprised of GF,, GF, and GF, at 25, 25 and 5% (w/w). Similarly Neosugar P contains above 95% (w/w) fructo-oligosaccharides comprised of GF2, GF, and GF, at 40,45 and 10% (w/w).
Useful characteristics and commercial applications
Fructo-oligosaccharides possess useful physical and physiological characteristics which make them widely applicable to foods and feedstuffs. As the saccharides are non-digestible, they pass through the small intestine without being absorbed and reach the large intestine where they are selectively utilized by bifidobacteria in the intestinal microflora. These two characteristics are the key to the usefulness of fructo-oligosaccharides for human health: relief of constipation, improvement of the blood lipid composition and suppression of the production of intestinal putrefactive substances.
Fructo-oligosaccharides are also useful for increasing the body weight gain and the feed efficiency rate of domestic animals.
Physical properties
Fructo-oligosaccharides are colourless and odourless, and can serve as high quality sweeteners. The sweetness of 'Neosugar G' and 'Neosugar P is about 60% and 30% of that of sucrose, respectively.
Both 'Neosugars' are stable at a neutral pH and at temperatures up to 140°C.
Non-digestibilit y
The fructo-oligosaccharides were not hydrolysed in the rat or man by digestive enzymes such as the disaccharidases of intestinal mucosa and a-amylase of pancreatic homogenates [ 51. Sugar tolerance tests on healthy subjects confirmed that fructo-oligosaccharides were neither digestible nor absorbable unlike their monosaccharide components, fructose and glucose. After the ingestion of sucrose, plasma glucosaemic, fructosaemic and insulin responses were rapidly observed, but fructo-oligosaccharide ingestion did not show any increase in the plasma concentration [6] .
Selective utilization by intestinal bacteria
It is well known that bifidobacteria and lactobacilli can be classified as beneficial intestinal bacteria, while some others like Escherichia coli and Clostridium pe7frngens are unfavourable for humans and animals in terms of both health and nutrition [7] . The utilization of several sugars by individual intestinal bacterial species was examined in vitro as shown in Although there was no significant difference, lactobacilli showed a tendency to increase from lo7.' to lo7.', and the occurrence of CL perfringens showed a tendency to decrease from 43.5% to 3 1.6%.
Relief of constipation
Fructo-oligosaccharides had a beneficial effect on constipation. Fifteen functionally constipated subjects ranging from 20 to 82 years old were administered fructo-oligosaccharides for 28 days. After ingestion of fructo-oligosaccharides, 1 1 subjects (73%) were improved in terms of constipation, and all the subjects were able to defecate more than once every 3 days [lo]. It is considered that the alleviation of constipation by non-digestible saccharides is partly due to the high osmotic pressure of short-chain fatty acids produced by the intestinal bacteria and the consequently accelerated peristaltic movement.
~~~~~~
Supress the production of putrefactive substances in intestine 564
Cholesterol reduction 
Suppression of putrefactive substances
The effect of fructo-oligosaccharides on the suppression of putrefaction in the intestine was investigated by feeding rats a diet containing tyrosine and tryptophan [8] . Phenol and p-cresol are putrefactive products produced from tyrosine. Indole is also a putrefactive product produced from tryptophan. Putrefactive products absorbed from the gut are conjugated with sulphuric or glucuronic acid in the liver and excreted in the urine. Faecal and urinary phenolic compounds increase in accordance with ageing or the addition of tyrosine. However, the administration of 0.4, 2.0 and 10% fructo-oligosaccharides to the diet showed a suppressive effect on the faecal and urinary phenolic compounds. The administration of the 10% diet especially resulted in a drastic decrease in the amount of phenolic compounds. On the other hand, the amount of indole in the faeces was very small in comparison with the faecal phenolic compounds, and no significant differences in the urinary indican (the potassium salt of indoxyl sulphate) were observed between each group. This effect was also confirmed in human subjects.
Bioavailabilit y
Utilization of fructo-oligosaccharides was investigated by a radiorespirometric study and anaerobic incubation of [U-14C]fructooligosaccharides with faeces [12] . When the labelled saccharides were ingested by healthy men, about 49% and 5.5% of the administered radioactivity was detected in the expired ' T O z after 24 and 48 h respectively, and the maximum rate of '"CO, excretion occurred at 7 h after administration. In the anaerobic incubation of the saccharides with the subjects' faeces, the saccharides were catabolized mainly to "CO, (9.6%) and short-chain fatty acids (SCFA, 57.8%), including acetic acid, propionic acid and butyric acid. Complemental interpretation of these two studies led to the elucidation of the catabolic pathway by which the [ l'C]fructo-oligosaccharides were fermented by intestinal bacteria into 1JC02 and ["C] SCFAs which were absorbed and utilized in man to give the respiratory "CO?. Therefore, caloric utilization of the saccharides was quantified by estimating the amount of the ["C] SCFAs absorbed from the colon, and the available energy was estimated to be between 1.5 and 2.0 kcal/g.
Fructo-oligosaccharides are not digested by the intestinal enzymes, and they thus reach the large intestine. They are subsequently fermented there, mainly to SCFA, by the gut micro-organisms. These SCFA have very important roles in relation to the digestive tract, intestinal micro-organisms and the activities of other organs such as the liver. 
Conclusion
Fructo-oligosaccharides are industrially produced from sucrose by the transfructosylating reaction of an A. niger enzyme. They have two characteristic properties, i.e., non-digestibility and selective utilization by intestinal bacteria. The beneficial effects of fructo-oligosaccharides on humans and animals are thought to be derived from these two properties, as shown in Fig. 2 . The non-digestible saccharides are utilized as nutrients by beneficial bacteria in the large intestine, and this selective utilization results in an increase in bifidobacteria, followed by production of SCFA, a lowered pH in the large intestine, and suppression of putrefactive substances. These favourable results are almost the same as those of dietary fibre functions, and they are now widely applied to foodstuffs and animal feeds.
Introduction
Essentially three types of non-structural storage carbohydrates are found in plants. These are starch, sucrose and fructans (a fructose polymer). Especially in the case of starch and sucrose, current day crop plants have been improved by classical breeding techniques to produce these carbohydrates in substantial quantities. However, a detailed understanding of the regulatory mechanisms which control the type, the amount and the tissue-specific synthesis of these carbohydrates is lacking, even though starch and sucrose accumulation in plants has been studied at the biochemical and physiological level for a long period of time.
The key regulatory events which determine carbohydrate storage type and quantities remain to be elucidated. This situation is likely to change in the near future because of the extraordinary power of molecular biology and genetics which is now being used to study questions related to sink-source interactions.
Abbreviations used: DP, degree of polymerization; SST, sucrose-sucrose fructosyltransferase; FFT, fructanfructan frutosyltransferase; CHI, cycloheximide.
In contrast to starch-and sucrose-accumulating plants, far less research has been performed on plants which store fructans. This is so in spite of the importance of fructan storage for a wide range of plants, among which are the economically important Grumineue species. From a molecular point of view two aspects make fructan metabolism research an interesting enterprise. First, modification of fructan biosynthesis in plants will change source-sink relations in plant cells and organs. For example, starch-and sucrose-accumulating plants can be induced to synthesize fructans by transgenic technology. The resulting effect on source-sink relations within the plant, and the adaptation to this change will provide an insight into the mechanisms which regulate carbon partitioning within the plant cell and the whole plant.
Secondly, fructan research is interesting with respect to the physiological parameters which govern fructan accumulation and breakdown. Whereas starch is located in the plastids and is an insoluble polymer, fructans are located in the vacuole and are soluble. Different plants and different plant organs have fructans of different length and linkage type. Remarkably, plants can modulate
